中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2010年
7期
814-816
,共3页
王合梅%贾慧群%雍芳芳%李超%王勇%赵伟
王閤梅%賈慧群%雍芳芳%李超%王勇%趙偉
왕합매%가혜군%옹방방%리초%왕용%조위
每搏输出量%血管容量
每搏輸齣量%血管容量
매박수출량%혈관용량
Stroke volume%Vascular capacitance
目的 评价每搏量变异度(SVV)与患者血容量变化的相关性.方法 择期胃癌根治术男性患者48例,年龄50～60岁,ASA分级Ⅱ级.麻醉诱导后30 min静脉输注6%羟乙基淀粉130/0.40.67 ml·kg-1·min-1,分别于输注前、输注羟乙基淀粉剂量达2、4、6、8、10、12、14、16、18 ml/kg时,记录SVV、CO、SV、CI和CVP.SVV、CO、SV、CI和CVP与羟乙基淀粉输注量行Spearman等级相关分析.结果 SVV、CO、SV、CI和CVP与羟乙基淀粉输注量之间的相关系数分别为:rSVV=-0.91±0.06,rCO=0.83±0.04,rSV=0.86±0.09,rCI=0.86±0.09,rCVP=0.90±0.03.5个相关系数中,rSVV最高,rCVP高于rCO、rSV和rCI(P＜0.05);rCO、rSV和rCI间比较差异无统计学意义(P＞0.05).结论 SVV与患者血容量变化相关性较高,可用于指导容量治疗.
目的 評價每搏量變異度(SVV)與患者血容量變化的相關性.方法 擇期胃癌根治術男性患者48例,年齡50～60歲,ASA分級Ⅱ級.痳醉誘導後30 min靜脈輸註6%羥乙基澱粉130/0.40.67 ml·kg-1·min-1,分彆于輸註前、輸註羥乙基澱粉劑量達2、4、6、8、10、12、14、16、18 ml/kg時,記錄SVV、CO、SV、CI和CVP.SVV、CO、SV、CI和CVP與羥乙基澱粉輸註量行Spearman等級相關分析.結果 SVV、CO、SV、CI和CVP與羥乙基澱粉輸註量之間的相關繫數分彆為:rSVV=-0.91±0.06,rCO=0.83±0.04,rSV=0.86±0.09,rCI=0.86±0.09,rCVP=0.90±0.03.5箇相關繫數中,rSVV最高,rCVP高于rCO、rSV和rCI(P＜0.05);rCO、rSV和rCI間比較差異無統計學意義(P＞0.05).結論 SVV與患者血容量變化相關性較高,可用于指導容量治療.
목적 평개매박량변이도(SVV)여환자혈용량변화적상관성.방법 택기위암근치술남성환자48례,년령50～60세,ASA분급Ⅱ급.마취유도후30 min정맥수주6%간을기정분130/0.40.67 ml·kg-1·min-1,분별우수주전、수주간을기정분제량체2、4、6、8、10、12、14、16、18 ml/kg시,기록SVV、CO、SV、CI화CVP.SVV、CO、SV、CI화CVP여간을기정분수주량행Spearman등급상관분석.결과 SVV、CO、SV、CI화CVP여간을기정분수주량지간적상관계수분별위:rSVV=-0.91±0.06,rCO=0.83±0.04,rSV=0.86±0.09,rCI=0.86±0.09,rCVP=0.90±0.03.5개상관계수중,rSVV최고,rCVP고우rCO、rSV화rCI(P＜0.05);rCO、rSV화rCI간비교차이무통계학의의(P＞0.05).결론 SVV여환자혈용량변화상관성교고,가용우지도용량치료.
Objective To evaluate the correlation between stroke volume variation (SVV) and the blood volume. Methods Forty-eight ASA Ⅱ male patients, aged 50-60 yr, scheduled for elective radical operation for gastric cancer, were studied. Anesthesia was induced with fentanyl 4 μg/kg, propofol 2 mg/kg and cis-atracurium 0.15 mg/kg and maintained with inhalation of 2%-3% sevoflurane. 6% HES 130/0.4 was infused intravenously at a rate of 0.67 ml· kg - 1 · min - 1 30 min after induction. SVV,cardiac output (CO),SV and cardiac index (CI) were monitored and recorded using the FloTrac/Vigileo (Edwards Lifesciences, USA) system before HES was infused and when the dose of HES reached 2, 4, 6, 8, 10, 12, 14, 16 and 18 ml/kg. CVP was also recorded at the corresponding time points. Spearman's rank sum correlation coefficient was used to analyze the data. Results Correlation coefficients between the amount of HES infused and CO, SV, CI or CVP were rSVV = - 0.91 ± 0.06,rCO = 0.83 ± 0.04, rSV = 0.86 ± 0.09, rCI = 0.86 ± 0.09 and rCVP = 0.90 ± 0.03. Among the 5 correlation coefficients, rSVV was the highest, rCVP was significantly higher than rCO, rSV and rCI (P ＜ 0.05), and there was no significant difference among rCO, rSV and r CI (P ＞ 0. 05). Conclusion SVV is highly correlated with the blood volume and can be used to guide volume therapy.
